These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing. Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478 [TBL] [Abstract][Full Text] [Related]
4. Common criteria among States for storage and use of dried blood spot specimens after newborn screening. Petrini C; Olivieri A; Corbetta C; Cerone R; D'Agnolo G; Bompiani A Ann Ist Super Sanita; 2012; 48(2):119-21. PubMed ID: 22751553 [TBL] [Abstract][Full Text] [Related]
7. Newborn dried blood spot samples in Denmark: the hidden figures of secondary use and research participation. Nordfalk F; Ekstrøm CT Eur J Hum Genet; 2019 Feb; 27(2):203-210. PubMed ID: 30287898 [TBL] [Abstract][Full Text] [Related]
8. Storage and use of residual dried blood spots. Webster D; ; Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():49-51. PubMed ID: 15906694 [TBL] [Abstract][Full Text] [Related]
9. Genomic Databases and Biobanks in Denmark. Hartlev M J Law Med Ethics; 2015; 43(4):743-53. PubMed ID: 26711414 [TBL] [Abstract][Full Text] [Related]
10. Robustness of genome-wide scanning using archived dried blood spot samples as a DNA source. Hollegaard MV; Grove J; Grauholm J; Kreiner-Møller E; Bønnelykke K; Nørgaard M; Benfield TL; Nørgaard-Pedersen B; Mortensen PB; Mors O; Sørensen HT; Harboe ZB; Børglum AD; Demontis D; Ørntoft TF; Bisgaard H; Hougaard DM BMC Genet; 2011 Jul; 12():58. PubMed ID: 21726430 [TBL] [Abstract][Full Text] [Related]
11. A comparative analysis of the governance and use of residual dried blood spots from state newborn screening programs and neonatal biobanks. Preslan ED; Mathews DJ J Empir Res Hum Res Ethics; 2013 Jul; 8(3):22-33. PubMed ID: 23933773 [TBL] [Abstract][Full Text] [Related]
12. Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: statement of the Council of Regional Networks for Genetic Services. Therrell BL; Hannon WH; Pass KA; Lorey F; Brokopp C; Eckman J; Glass M; Heidenreich R; Kinney S; Kling S; Landenburger G; Meaney FJ; McCabe ER; Panny S; Schwartz M; Shapira E Biochem Mol Med; 1996 Apr; 57(2):116-24. PubMed ID: 8733889 [TBL] [Abstract][Full Text] [Related]
16. Public's attitudes on participation in a biobank for research: an Italian survey. Porteri C; Pasqualetti P; Togni E; Parker M BMC Med Ethics; 2014 Nov; 15():81. PubMed ID: 25425352 [TBL] [Abstract][Full Text] [Related]
17. Implementation of informed consent for a cystic fibrosis newborn screening program in France: low refusal rates for optional testing. Dhondt JL J Pediatr; 2005 Sep; 147(3 Suppl):S106-8. PubMed ID: 16202772 [TBL] [Abstract][Full Text] [Related]
18. Testing an online, dynamic consent portal for large population biobank research. Thiel DB; Platt J; Platt T; King SB; Fisher N; Shelton R; Kardia SL Public Health Genomics; 2015; 18(1):26-39. PubMed ID: 25359560 [TBL] [Abstract][Full Text] [Related]
19. State laws regarding the retention and use of residual newborn screening blood samples. Lewis MH; Goldenberg A; Anderson R; Rothwell E; Botkin J Pediatrics; 2011 Apr; 127(4):703-12. PubMed ID: 21444595 [TBL] [Abstract][Full Text] [Related]